Holen Sie sich die Stockscreener-App
1.50
0.33%
0.005
Vorhandelsmarkt:
1.54
0.04
+2.67%
Schlusskurs vom Vortag:
$1.495
Offen:
$1.5
24-Stunden-Volumen:
154.72K
Relative Volume:
0.68
Marktkapitalisierung:
$3.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.34M
KGV:
-0.2101
EPS:
-7.14
Netto-Cashflow:
$-6.69M
1W Leistung:
+0.67%
1M Leistung:
-6.54%
6M Leistung:
-51.14%
1J Leistung:
-87.27%
1-Tages-Spanne:
$1.4641
$1.55
1-Wochen-Bereich:
$1.41
$1.64
52-Wochen-Spanne:
$1.25
$16.63
Painreform Ltd Stock (PRFX) Company Profile
Vergleichen Sie PRFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRFX
Painreform Ltd
|
1.50 | 3.00M | 0 | -9.34M | -6.69M | -7.14 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Painreform Ltd Aktie (PRFX) Neueste Nachrichten
PainReform Ltd. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com
What analysts say about PainReform Ltd. stockExceptional trading results - jammulinksnews.com
Is PainReform Ltd. a good long term investmentHigh-yield growth strategies - jammulinksnews.com
Is PainReform Ltd. stock overhyped or has real potentialFree Day Trading Recommendations - Newser
What makes PainReform Ltd. stock price move sharplyWealth Building Stock Portfolio - Newser
What drives PainReform Ltd. stock priceHigh-velocity gains - jammulinksnews.com
How PainReform Ltd. stock performs during market volatilityFree Popular Stock Recommendations - Newser
Why PainReform Ltd. stock attracts strong analyst attentionFree Stock Selection - Newser
PainReform (NASDAQ:PRFX) Trading Up 0.7% – Here’s Why - Defense World
Painreform Shares Drop 11% After Revealing Strategic Stake in LayerBio - MSN
PainReform Ltd. enters into a Strategic Investment - GlobeNewswire
LayerBio, Inc. announced that it expects to receive $3 million in funding from PainReform Ltd. - MarketScreener
LayerBio, Inc. announced that it expects to receive $2.95 million in funding from PainReform Ltd. - MarketScreener
Painreform stock falls after announcing strategic investment in LayerBio By Investing.com - Investing.com Australia
PainReform invests in LayerBio to expand into ophthalmology By Investing.com - Investing.com South Africa
PainReform Expands into Ophthalmology with Strategic Investment in LayerBio - TipRanks
PRFX SEC FilingsPainreform Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
PainReform Ltd. enters into a Strategic Investment Agreement to - GuruFocus
PainReform Targets 3M Annual Cataract Surgeries with Revolutionary Dropless Pain Treatment - Stock Titan
Blade Ranger: Consideration from PainReform Transaction Continue - GuruFocus
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales | PRFX Stock News - GuruFocus
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales - Yahoo Finance
Blade Ranger Gains Million-Share Stake in PainReform: Software Sales Trigger $2M Zero-Cost Warrant Conversion - Stock Titan
What Lies Ahead For PainReform Ltd (NASDAQ: PRFX) In 2025? - Stocksregister
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Launches AI Pilot with Econergy in Romania - TipRanks
PainReform Ltd. Launches Strategic Pilot Program with Econergy Renewable Energy Ltd. to Optimize Solar Energy Production using DeepSolar™ Platform - Nasdaq
PainReform Launches Strategic AI Pilot with Econergy Using - GlobeNewswire
PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar Projects - Stock Titan
PainReform Regains Nasdaq Compliance as of April 16, 2025 - TipRanks
PainReform Ltd’s Market Journey: Closing Weak at 2.08, Down -3.26 - DWinneX
PainReform Moves Towards Nasdaq Compliance with Strategic Acquisition - TipRanks
PainReform (PRFX) Expands Into Clean Energy Following DeepSolar Acquisition - GuruFocus
PainReform (PRFX) to Acquire AI-Driven Solar Analytics Platform DeepSolar - GuruFocus
PainReform (PRFX) Acquires AI-Driven Solar Platform DeepSolar - GuruFocus
PainReform (PRFX) Completes Acquisition of AI Solar Platform Dee - GuruFocus
PainReform (PRFX) Soars on DeepSolar Acquisition - GuruFocus
Finanzdaten der Painreform Ltd-Aktie (PRFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):